MedPath

Flecainide Acetate

Flecainide Acetate Tablets, USP Rx only

Approved
Approval ID

2013e6ef-9141-42c3-8ea8-285840ecdd15

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 9, 2023

Manufacturers
FDA

Bryant Ranch Prepack

DUNS: 171714327

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Flecainide Acetate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code63629-7982
Application NumberANDA202821
Product Classification
M
Marketing Category
C73584
G
Generic Name
Flecainide Acetate
Product Specifications
Route of AdministrationORAL
Effective DateNovember 11, 2020
FDA Product Classification

INGREDIENTS (6)

CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48
Classification: IACT
FLECAINIDE ACETATEActive
Quantity: 100 mg in 1 1
Code: M8U465Q1WQ
Classification: ACTIB
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
HYDROGENATED COTTONSEED OILInactive
Code: Z82Y2C65EA
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Flecainide Acetate - FDA Drug Approval Details